Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Operating Leases (2019 - 2026)

Healthcare Services has reported Operating Leases over the past 8 years, most recently at $14.7 million for Q1 2026.

  • Quarterly Operating Leases fell 11.09% to $14.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.7 million through Mar 2026, down 11.09% year-over-year, with the annual reading at $9.7 million for FY2025, 20.24% up from the prior year.
  • Operating Leases was $14.7 million for Q1 2026 at Healthcare Services, up from $9.7 million in the prior quarter.
  • Over five years, Operating Leases peaked at $18.6 million in Q2 2024 and troughed at $6.2 million in Q3 2025.
  • The 5-year median for Operating Leases is $14.1 million (2023), against an average of $13.1 million.
  • Biggest five-year swings in Operating Leases: skyrocketed 78.57% in 2023 and later plummeted 63.57% in 2025.
  • Tracing HCSG's Operating Leases over 5 years: stood at $8.1 million in 2022, then surged by 38.76% to $11.2 million in 2023, then decreased by 28.5% to $8.0 million in 2024, then rose by 20.24% to $9.7 million in 2025, then skyrocketed by 51.71% to $14.7 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods came in at $14.7 million, $9.7 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.